<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="drrs" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">drrs</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">SALL4</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kohlhase</surname>
            <given-names>J&#x000fc;rgen</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Center for Human Genetics<break/>Freiburg, Germany</aff>
          <email>jkohlhase@humangenetik-freiburg.de</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-08-16" date-type="created">
          <day>16</day>
          <month>8</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2015-01-15" date-type="updated">
          <day>15</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date iso-8601-date="2008-03-12" date-type="revised">
          <day>12</day>
          <month>3</month>
          <year>2008</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="rss" document-type="chapter">Russell-Silver Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="samd9l-ap" document-type="chapter"><italic toggle="yes">SAMD9L</italic>-Related Ataxia-Pancytopenia Syndrome</related-object>
      <abstract id="drrs.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SALL4</italic>-related disorders include Duane-radial ray syndrome (DRRS, Okihiro syndrome), acro-renal-ocular syndrome (AROS), and <italic toggle="yes">SALL4</italic>-related Holt-Oram syndrome (HOS), three phenotypes previously thought to be distinct entities:</p>
          <list list-type="bullet">
            <list-item>
              <p>DRRS is characterized by uni- or bilateral Duane anomaly and radial ray malformation that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs, hypoplasia or aplasia of the radii, shortening and radial deviation of the forearms, triphalangeal thumbs, and duplication of the thumb (preaxial polydactyly).</p>
            </list-item>
            <list-item>
              <p>AROS is characterized by radial ray malformations, renal abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, vesico-ureteral reflux, bladder diverticula), ocular coloboma, and Duane anomaly.</p>
            </list-item>
            <list-item>
              <p>Rarely, pathogenic variants in <italic toggle="yes">SALL4</italic> may cause clinically typical HOS (i.e., radial ray malformations and cardiac malformations without additional features).</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis is based on clinical findings and presence of a heterozygous <italic toggle="yes">SALL4</italic> pathogenic variant.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Surgery as needed for strabismus from Duane anomaly, malformations of the forearms, and congenital heart defects; antiarrhythmic medications or pacemaker for those with conduction defects or heart block; hearing aids as needed; consideration of growth hormone therapy for treating children with growth retardation.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> A cardiologist can assist in determining the need for anticoagulants and antibiotic prophylaxis for bacterial endocarditis (SBE).</p>
          <p><italic toggle="yes">Surveillance:</italic> In those at risk for conduction defects, ECG at least annually with consideration of annual Holter monitor in those with known conduction defects; periodic echocardiographic surveillance may be recommended for individuals with certain congenital heart defects; routine monitoring of renal function in those with renal anomalies, even if renal function is normal initially; periodic renal ultrasound evaluation if renal position anomalies could cause obstruction; at least yearly blood counts in those with a history of thrombocytopenia and leukocytosis.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs affecting the kidney if renal function is impaired, or the inner ear if hearing is impaired. Certain medications may be contraindicated in those with arrhythmias.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">SALL4</italic>-related disorders are inherited in an autosomal dominant manner. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is approximately 40%-50%. Each child of an individual with a <italic toggle="yes">SALL4</italic>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="drrs.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="drrs.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_drrs.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SALL4</italic>-Related Disorders: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_drrs.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Duane-radial ray syndrome/Okihiro syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Acro-renal-ocular syndrome</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">SALL4</italic>-related Holt-Oram syndrome</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="drrs.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="drrs.Diagnosis">
        <title>Diagnosis</title>
        <sec id="drrs.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><italic toggle="yes">SALL4</italic>-related disorders include a spectrum of phenotypes previously thought to be distinct entities: Duane-radial ray syndrome (DRRS), or Okihiro syndrome; acro-renal-ocular syndrome (AROS) [<xref ref-type="bibr" rid="drrs.REF.kohlhase.2003.473">Kohlhase et al 2003</xref>]; and <italic toggle="yes">SALL4</italic>-related Holt-Oram syndrome (HOS).</p>
          <p><bold>Duane-radial ray syndrome/Okihiro syndrome</bold> is established clinically in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Duane anomaly,</bold> characterized by uni- or bilateral limitation of abduction of the eye associated with retraction of the globe and narrowing of the palpebral fissure on adduction. The abducens nucleus and nerve (cranial nerve VI) are absent and the lateral rectus muscle is innervated by a branch of the oculomotor nerve (cranial nerve III), which explains the aberrant ocular movements (see <related-object link-type="booklink" source-id="gene" document-id="duane" document-type="chapter">Duane Syndrome</related-object>).</p>
            </list-item>
            <list-item>
              <p><bold>Radial ray malformation.</bold> Malformations can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs; hypoplasia or aplasia of the radii; shortening and radial deviation of the forearms; triphalangeal thumbs; and duplication of the thumb (preaxial polydactyly).</p>
            </list-item>
            <list-item>
              <p><bold>Other features</bold> that are variably present; see <xref ref-type="sec" rid="drrs.Clinical_Characteristics">Clinical Characteristics</xref>.</p>
            </list-item>
          </list>
          <p><bold>Acro-renal-ocular syndrome</bold> is established clinically in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Radial ray malformations</p>
            </list-item>
            <list-item>
              <p>Renal abnormalities that can include mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, vesico-ureteral reflux, and bladder diverticula</p>
            </list-item>
            <list-item>
              <p>Ocular abnormalities that can include ocular coloboma and Duane anomaly</p>
            </list-item>
          </list>
          <p><bold><italic toggle="yes">SALL4</italic>-related Holt-Oram syndrome (HOS)</bold> is characterized by the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Upper-extremity malformations involving radial, thenar, and/or carpal bones, including preaxial polydactyly</p>
            </list-item>
            <list-item>
              <p>Congenital heart malformations, including ventricular septal defects, atrial septal defects, and tetralogy of Fallot</p>
            </list-item>
            <list-item>
              <p>Cardiac conduction defects (less common than in <italic toggle="yes">TBX5</italic>-related HOS)Note: HOS is a heterogeneous phenotype in which 70% of affected individuals have pathogenic variants in <italic toggle="yes">TBX5</italic>; see <xref ref-type="sec" rid="drrs.Differential_Diagnosis">Differential Diagnosis</xref> and <related-object link-type="booklink" source-id="gene" document-id="hos" document-type="chapter">Holt-Oram Syndrome</related-object> for further clinical information on this condition.</p>
            </list-item>
          </list>
        </sec>
        <sec id="drrs.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">SALL4</italic> is the only gene mutated in Duane-radial ray/Okihiro syndrome (DRRS), acro-renal-ocular syndrome (AROS), and <italic toggle="yes">SALL4</italic>-related Holt-Oram syndrome (HOS).</p>
          <p><bold>One genetic testing strategy</bold> is <italic toggle="yes">SALL4</italic> sequence analysis, followed by deletion/duplication analysis if a pathogenic variant is not identified (<xref ref-type="table" rid="drrs.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">SALL4</italic> and other genes of interest (see <xref ref-type="sec" rid="drrs.Differential_Diagnosis">Differential Diagnosis</xref>). The genes included and the methods used in multi-gene panels vary by laboratory and over time. Note: (1) Panel testing should be considered only if the phenotype falls outside of the typical spectrum of <italic toggle="yes">SALL4</italic>-related disorders. (2) Panel testing may not detect larger deletions in the genes included.</p>
          <table-wrap id="drrs.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">SALL4</italic>-Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SALL4</italic>
                  </td>
                  <td headers="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x02264;80%&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_drrs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10%-15%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="drrs.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="drrs" object-id="drrs.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="drrs.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="drrs.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="drrs.TF.1.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="drrs.REF.albaradie.2002.1195">Al-Baradie et al [2002]</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2002.2979">Kohlhase et al [2002]</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2003.473">Kohlhase et al [2003]</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2004b.e102">Borozdin et al [2004b]</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2005.176">Kohlhase et al [2005]</xref></p>
              </fn>
              <fn id="drrs.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="drrs.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al [2004a]</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2007.830">Borozdin et al [2007]</xref></p>
              </fn>
              <fn id="drrs.TF.1.6">
                <label>6. </label>
                <p>FISH analysis detects deletions; however, given the relatively small size of the gene, FISH analysis may have a low yield / limited utility.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="drrs.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="drrs.Clinical_Description">
          <title>Clinical Description</title>
          <p>In addition to the clinical features described in <xref ref-type="sec" rid="drrs.Diagnosis">Diagnosis</xref>, the clinical manifestations of <italic toggle="yes">SALL4</italic>-related disorders may include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Eyes.</bold> Microphthalmia (rare); iris, retinal, and choroidal colobomata; cataract; optic disc hypoplasia</p>
            </list-item>
            <list-item>
              <p><bold>Upper extremities.</bold> Concomitant shortening of ulnae, syndactyly, radial clubhand, shortened humeri, hypoplasia of deltoid muscles</p>
            </list-item>
            <list-item>
              <p><bold>Kidneys.</bold> Renal agenesis, crossed renal ectopia, position anomalies of kidneys</p>
            </list-item>
            <list-item>
              <p><bold>Ears/hearing.</bold> Sensorineural and/or conductive deafness, abnormal pinnae, slit-like opening of auditory canals, small ears</p>
            </list-item>
            <list-item>
              <p><bold>Heart.</bold> Atrial septal defect, ventricular septal defect, tetralogy of Fallot</p>
            </list-item>
            <list-item>
              <p><bold>Gastrointestinal.</bold> Anal stenosis, imperforate anus</p>
            </list-item>
            <list-item>
              <p><bold>Face.</bold> Epicanthal folds, widely spaced eyes , depressed nasal bridge, hemifacial microsomia</p>
            </list-item>
            <list-item>
              <p><bold>Lower extremities.</bold> Talipes, clubfoot, tibial hemimelia, syndactyly of toes</p>
            </list-item>
            <list-item>
              <p><bold>Spine.</bold> Fused vertebrae</p>
            </list-item>
            <list-item>
              <p><bold>Pituitary.</bold> Growth hormone deficiency, postnatal growth retardation, pituitary hypoplasia</p>
            </list-item>
            <list-item>
              <p><bold>Central nervous system.</bold> Neural tube defects (rare); meningomyelocele has been observed in two affected individuals [J Kohlhase, unpublished results].</p>
            </list-item>
            <list-item>
              <p><bold>Blood.</bold> Mild thrombocytopenia and leukocytosis; present in some individuals with <italic toggle="yes">SALL4</italic> pathogenic variants [<xref ref-type="bibr" rid="drrs.REF.paradisi.2007.326">Paradisi &#x00026; Arias 2007</xref>]; see <xref ref-type="sec" rid="drrs.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</xref>.</p>
            </list-item>
          </list>
          <p>Of 69 affected individuals from 23 families with a <italic toggle="yes">SALL4</italic> pathogenic variant, 13% show the triad of Duane anomaly, radial ray malformation, and sensorineural hearing loss originally described for Okihiro syndrome; 45% have Duane anomaly and radial defects; and 21% have radial defects only. In 82.6% of families, at least one person has Duane anomaly and in 48%, at least one person has hearing loss. Radial ray malformations have been found in all families with a <italic toggle="yes">SALL4</italic> pathogenic variant and in 91.3% of individuals with a pathogenic variant. Sixty-five percent of individuals with a <italic toggle="yes">SALL4</italic> pathogenic variant have Duane anomaly and 16% have hearing loss [data collected in 2004 from published reports and unpublished cases compiled by the Author].</p>
        </sec>
        <sec id="drrs.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Most pathogenic variants are private or have been observed in no more than three independent families. The phenotype of larger deletions (not extending into other genes) is not significantly different from that caused by almost all truncating single-nucleotide variants, and these are expected to result in nonsense-mediated mRNA decay.</p>
          <p>The only clearly pathogenic missense variant identified so far (<xref ref-type="table" rid="drrs.T.sall4_pathogenic_allelic_variants">c.2663A&#x0003e;G</xref>, p.His633Arg) affects an essential coordinating amino acid and is associated with central midline defects (single upper incisor, pituitary hypoplasia, widely spaced eyes). It is predicted to result in an increase of DNA binding capacity [<xref ref-type="bibr" rid="drrs.REF.miertus.2006.154">Miertus et al 2006</xref>].</p>
          <p>The only truncating pathogenic variant predicted to escape nonsense-mediated mRNA decay is associated with extensive clinical variability and severe hemifacial microsomia in one affected member of the reported family [<xref ref-type="bibr" rid="drrs.REF.terhal.2006.222">Terhal et al 2006</xref>].</p>
          <p>Persons with Okihiro syndrome and developmental delay are likely to have a larger deletion including <italic toggle="yes">SALL4</italic> and neighboring genes [<xref ref-type="bibr" rid="drrs.REF.borozdin.2007.830">Borozdin et al 2007</xref>]. Developmental delay/intellectual disability associated with a pathogenic variant within <italic toggle="yes">SALL4</italic> has not been observed.</p>
        </sec>
        <sec id="drrs.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is approximately 95%, but may be lower for certain pathogenic variants.</p>
          <p>In two reported families [<xref ref-type="bibr" rid="drrs.REF.hayes.1985.273">Hayes et al 1985</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2002.2979">Kohlhase et al 2002</xref>]: either an individual known (on the basis of pedigree position) to have the <italic toggle="yes">SALL4</italic> pathogenic variant is unaffected, or an individual with a proven <italic toggle="yes">SALL4</italic> pathogenic variant shows no signs of a <italic toggle="yes">SALL4</italic>-related disorder. In the latter family, however, the phenotype was mild in all individuals with the pathogenic variant (i.e., presenting with only thenar hypoplasia and Duane anomaly).</p>
          <p>Of 69 family members known in 2004 to have a <italic toggle="yes">SALL4</italic> pathogenic variant, only one (1.4%) was clinically unaffected [J Kohlhase, personal observation]. No further case of non-penetrance are known to the author.</p>
        </sec>
        <sec id="drrs.Anticipation">
          <title>Anticipation</title>
          <p>Apparent increased severity in successive generations is attributed to ascertainment bias.</p>
        </sec>
        <sec id="drrs.Nomenclature">
          <title>Nomenclature</title>
          <p>One of the earliest reports of Duane anomaly occurring together with radial ray defects is that of <xref ref-type="bibr" rid="drrs.REF.ferrell.1966.630">Ferrell et al [1966]</xref> (earlier reports are cited in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607323">OMIM</ext-link>). Further families were reported by <xref ref-type="bibr" rid="drrs.REF.temtamy.1975.344">Temtamy et al [1975]</xref> and <xref ref-type="bibr" rid="drrs.REF.okihiro.1977.174">Okihiro et al [1977]</xref>. <xref ref-type="bibr" rid="drrs.REF.temtamy.1978">Temtamy &#x00026; McKusick [1978]</xref> named the syndrome Duane/radial dysplasia syndrome [DR syndrome, later modified to Duane-radial ray syndrome (DRRS)]. The term Okihiro syndrome was first used by <xref ref-type="bibr" rid="drrs.REF.hayes.1985.273">Hayes et al [1985]</xref>.</p>
          <p>The term 'Acro-renal-ocular syndrome' was used in 1984 to describe a family with autosomal dominant inheritance of thumb abnormalities, renal malformations, and ocular coloboma, ptosis, and Duane anomaly [<xref ref-type="bibr" rid="drrs.REF.halal.1984.753">Halal et al 1984</xref>].</p>
          <p>The term &#x02018;Holt-Oram syndrome&#x02019; has been referred to as heart-hand syndrome, a nonspecific designation that could apply to any number of conditions with involvement of these structures.</p>
        </sec>
        <sec id="drrs.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence is unknown, partly because in many countries <italic toggle="yes">SALL4</italic>-related disorders have not been and are still not differentiated from Holt-Oram syndrome caused by pathogenic variants in <italic toggle="yes">TBX5</italic> or from other hand-heart syndromes.</p>
        </sec>
      </sec>
      <sec id="drrs.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>IVIC (Instituto Venezolano de Investigaciones Cientificas) syndrome</bold> was described initially in six generations of a family with radial ray defects of variable degree, involvement of the extraocular muscles, congenital hearing impairment, mild thrombocytopenia, and leukocytosis; penetrance within this family was complete. Imperforate anus and kidney malrotation occurred in some affected individuals [<xref ref-type="bibr" rid="drrs.REF.arias.1980.25">Arias et al 1980</xref>].</p>
        <p>IVIC syndrome is clinically almost identical to DRRS with the exception of mild thrombocytopenia and leukocytosis before age 50 years. Additional clinical features include sensorineural and/or conductive deafness. It is unclear if IVIC syndrome truly represents a condition that is distinct from DRRS or if the additional features seen in individuals with IVIC syndrome are rare or underascertained findings within the spectrum of DRRS.</p>
        <p><bold>Isolated ventricular septal defects (VSD).</bold> Two <italic toggle="yes">SALL4</italic> missense variants have been reported to be associated with isolated VSD. However, since neither of these missense variants affects amino acids with known functional domains, it is unclear if this phenotype is clearly associated with pathogenic variants in <italic toggle="yes">SALL4</italic>.</p>
        <p><bold>Premature ovarian failure.</bold> Two <italic toggle="yes">SALL4</italic> missense variants have been reported to be associated with premature ovarian failure. However, since neither of these missense variants affects amino acids with known functional domains, it is unclear if this phenotype is clearly associated with pathogenic variants in <italic toggle="yes">SALL4</italic>.</p>
      </sec>
      <sec id="drrs.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="hos" document-type="chapter"><bold>Holt-Oram syndrome</bold></related-object><bold>.</bold> The main differential diagnosis is Holt-Oram syndrome (HOS) caused by pathogenic variants in <italic toggle="yes">TBX5</italic>. HOS is characterized by upper-limb malformations involving radial, thenar, or carpal bones; a personal and/or family history of congenital heart malformation, most commonly ostium secundum atrial septal defect (ASD) and ventricular septal defect (VSD), especially those occurring in the muscular trabeculated septum; and cardiac conduction defects. <italic toggle="yes">TBX5</italic>-related Holt-Oram syndrome and <italic toggle="yes">SALL4</italic>-related HOS have the same type of radial ray malformations, although preaxial polydactyly is almost exclusively associated with <italic toggle="yes">SALL4</italic> pathogenic variants and is extremely rare in those with a <italic toggle="yes">TBX5</italic> pathogenic variant (a single case is known to the author). The heart defects seen in those with <italic toggle="yes">SALL4</italic>-related disorders and HOS caused by pathogenic variants in <italic toggle="yes">TBX5</italic> are similar [<xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>] but ASD may be more common than VSD with mutation of <italic toggle="yes">TBX5</italic>, whereas the opposite may apply for <italic toggle="yes">SALL4</italic>. Pathogenic variants of both genes may result in more severe heart defects like tetralogy of Fallot, but cardiac conduction defects have been observed less commonly with <italic toggle="yes">SALL4</italic> pathogenic variants than with <italic toggle="yes">TBX5</italic> pathogenic variants. Individuals with typical radial ray malformations and a renal or urogenital malformation (especially position anomalies of the kidneys), but without Duane anomaly, are more likely to have a <italic toggle="yes">SALL4</italic> pathogenic variant than a <italic toggle="yes">TBX5</italic> pathogenic variant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="tbs" document-type="chapter"><bold>Townes-Brocks syndrome</bold></related-object><bold>.</bold> This syndrome is characterized by a triad of dysplastic ears, imperforate anus, and triphalangeal thumbs/preaxial polydactyly [<xref ref-type="bibr" rid="drrs.REF.powell.1999.89">Powell &#x00026; Michaelis 1999</xref>]. Townes-Brocks syndrome is associated with mutation of <italic toggle="yes">SALL1</italic>. In a few individuals, complete overlap exists between Okihiro syndrome and Townes-Brocks syndrome [<xref ref-type="bibr" rid="drrs.REF.kohlhase.2002.2979">Kohlhase et al 2002</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>]. In these individuals, <italic toggle="yes">SALL4</italic> molecular genetic testing should be considered if Duane anomaly is present and if <italic toggle="yes">SALL1</italic> molecular genetic testing does not reveal a pathogenic variant. Because radial aplasia has not been observed in individuals with mutation of <italic toggle="yes">SALL1</italic> [J Kohlhase, unpublished data], its presence points towards mutation of <italic toggle="yes">SALL4</italic> even when all other features suggest Townes-Brocks syndrome.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter"><bold>Fanconi anemia</bold></related-object><bold>.</bold> Individuals with radial ray malformations may also have Fanconi anemia. A range of additional features may be present, including other skeletal anomalies, heart defects, urogenital and renal anomalies, hypogonadism, ear anomalies, hearing loss, eye anomalies, imperforate anus, growth retardation, pigmentation anomalies, and developmental delay. Persons with Fanconi anemia often show blood cell count anomalies (a very rare finding in individuals with <italic toggle="yes">SALL4</italic> pathogenic variants) and develop progressive bone marrow failure with pancytopenia. There is a significant risk for leukemia and solid tumors. Developmental delay is not a feature of <italic toggle="yes">SALL4</italic>-related disorders apart from rare persons with multi-gene deletions that include <italic toggle="yes">SALL4</italic> [J Kohlhase, unpublished data], and Duane anomaly is not a feature of Fanconi anemia. Persons with radial ray anomalies and involvement of other organs who do not present with typical findings of Okihiro syndrome/AROS should be evaluated for Fanconi anemia by appropriate tests (i.e., chromosomal aberrations [breaks, radial figures] after cell cultivation in medium with DEB [diepoxybutane] and/or mitomycin C; see <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi Anemia</related-object> for details).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="tar" document-type="chapter"><bold>Thrombocytopenia-absent radius (TAR) syndrome</bold></related-object><bold>.</bold> Individuals with TAR syndrome have radial aplasia, but in contrast to <italic toggle="yes">SALL4</italic>-related disorders, the thumbs are never absent, although they may appear malformed. Thromobocytopenia does not typically occur in <italic toggle="yes">SALL4</italic>-related disorders; it may be only transiently detectable in TAR syndrome. Several other malformations may occur in TAR syndrome [<xref ref-type="bibr" rid="drrs.REF.greenhalgh.2002.876">Greenhalgh et al 2002</xref>]. <italic toggle="yes">RBM8A</italic> is the only gene in which biallelic pathogenic variants are known to cause TAR syndrome. One allele is typically inactivated by a minimally deleted region of 200 kb at chromosome band 1q21.1 (including <italic toggle="yes">RBM8A)</italic>, which is distinct from the region involved in the 1q21.1 deletion/duplication syndrome [<xref ref-type="bibr" rid="drrs.REF.klopocki.2007.232">Klopocki et al 2007</xref>, <xref ref-type="bibr" rid="drrs.REF.mefford.2008.1685">Mefford et al 2008</xref>]. The second allele is hypomorphic (i.e., demonstrates partial loss of gene function in the noncoding region of <italic toggle="yes">R8BM8A</italic>) [<xref ref-type="bibr" rid="drrs.REF.albers.2012">Albers et al 2012</xref>].</p>
        <p><bold>Arthrogryposis-ophthalmoplegia syndrome.</bold> In this syndrome, Duane anomaly is associated with deafness, muscle wasting, and contractures, but not typical radial limb malformations. A <italic toggle="yes">SALL4</italic> pathogenic variant was not identified in one of the few families reported [<xref ref-type="bibr" rid="drrs.REF.mccann.2005.123">McCann et al 2005</xref>].</p>
        <p><bold>Wildervanck syndrome.</bold> The Wildervanck syndrome consists of congenital perceptive deafness, Klippel-Feil anomaly, and Duane anomaly. The disorder affects almost exclusively females. The cause of Wildervanck syndrome is unknown. <italic toggle="yes">SALL4</italic> pathogenic variants have not been detected in some persons who meet the diagnostic criteria for Wildervanck syndrome [J Kohlhase, unpublished data].</p>
        <p><bold>Thalidomide embryopathy.</bold> From 1957 to 1962, malformed children were born to mothers who took the drug thalidomide for treatment of nausea and insomnia during pregnancy. Currently, thalidomide is prescribed to treat conditions such as multiple myeloma, HIV, and leprosy. Fetal abnormalities related to thalidomide administration during pregnancy include amelia, phocomelia, radial hypoplasia, external ear abnormalities (including anotia, microtia, micropinna), facial palsy, eye abnormalities (anophthalmos, microphthalmos, Duane anomaly, cranial nerve misrouting resulting in "crocodile tears"), and congenital heart defects. Alimentary tract, urinary tract, and genital malformations also occur. Mortality at or shortly after birth is approximately 40% [<xref ref-type="bibr" rid="drrs.REF.miller.1999.306">Miller &#x00026; Str&#x000f6;mland 1999</xref>]. If an individual with a diagnosis of thalidomide embryopathy has a child with radial ray malformations similar to those seen in Holt-Oram syndrome and <italic toggle="yes">SALL4</italic>-related disorders and additional malformations (i.e., Duane anomaly or kidney defects), a <italic toggle="yes">SALL4</italic> pathogenic variant is more likely to be found than a <italic toggle="yes">TBX5</italic> pathogenic variant [<xref ref-type="bibr" rid="drrs.REF.kohlhase.2003.473">Kohlhase et al 2003</xref>].</p>
        <p>
          <bold>Testing strategy for individuals with typical radial ray malformations</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Perform cardiac evaluation, ophthalmologic examination, and renal ultrasound examination in addition to a routine physical examination.</p>
          </list-item>
          <list-item>
            <p>If no features typical of <italic toggle="yes">SALL4</italic>-related disorders are found, <italic toggle="yes">TBX5</italic> molecular genetic testing is suggested as the first molecular test.</p>
          </list-item>
          <list-item>
            <p>If other features typical of <italic toggle="yes">SALL4</italic>-related disorders are found, <italic toggle="yes">SALL4</italic> molecular genetic testing is suggested as the first step.</p>
          </list-item>
          <list-item>
            <p>If clinical overlap exists with Townes-Brocks syndrome, <italic toggle="yes">SALL1</italic> molecular genetic testing should be the first test if the radial ray malformations do not include malformations of the radius itself; if malformation of the radius is present, <italic toggle="yes">SALL4</italic> molecular genetic testing is suggested as the first molecular test.</p>
          </list-item>
        </list>
      </sec>
      <sec id="drrs.Management">
        <title>Management</title>
        <sec id="drrs.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">SALL4</italic>-related disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Eyes.</bold> A complete eye examination by an ophthalmologist with special attention to extraocular movements and structural eye defects</p>
            </list-item>
            <list-item>
              <p><bold>Heart.</bold> Baseline evaluation by a cardiologist including an echocardiogram and an ECG. If suspected, more extensive evaluation for cardiac conduction defects may be needed especially when structural heart defects are present.</p>
            </list-item>
            <list-item>
              <p><bold>Kidneys.</bold> Renal ultrasound examination and routine laboratory tests for renal function</p>
            </list-item>
            <list-item>
              <p><bold>Hearing.</bold> See <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Hereditary Hearing Loss and Deafness Overview</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>Endocrine.</bold> If growth retardation is present, consideration of evaluation for growth hormone deficiency</p>
            </list-item>
            <list-item>
              <p><bold>Blood.</bold> Baseline CBC to evaluate for thrombocytopenia and/or leukocytosis.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Clinical genetics consultation</bold>
              </p>
            </list-item>
          </list>
        </sec>
        <sec id="drrs.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Duane anomaly.</bold> Severe strabismus may require eye surgery.</p>
          <p><bold>Radial ray malformations.</bold> Severe malformations of the forearms may require surgery, e.g., surgery to correct aplasia of the thumb by constructing a functional thumb (pollicization).</p>
          <p><bold>Heart defects.</bold> Cardiac surgery, if required for a congenital heart defect, is standard. A cardiologist can assist in determining the need for antiarrhythmic medications and surgery. Individuals with severe heart block may require pacemaker implantation.</p>
          <p><bold>Hearing deficits.</bold> Hearing aids may be required.</p>
          <p><bold>Growth retardation.</bold> Growth hormone therapy should be considered for treating affected children.</p>
        </sec>
        <sec id="drrs.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>A cardiologist can assist in determining the need for anticoagulants and antibiotic prophylaxis for bacterial endocarditis (SBE).</p>
        </sec>
        <sec id="drrs.Surveillance">
          <title>Surveillance</title>
          <p>In those with cardiac malformations or conduction defects:</p>
          <list list-type="bullet">
            <list-item>
              <p>ECG is indicated annually or more often in individuals diagnosed with a conduction defect, as well as in individuals at risk for developing a conduction defect.</p>
            </list-item>
            <list-item>
              <p>ECG should be combined with annual Holter monitor in individuals with known conduction disease to assess progression.</p>
            </list-item>
            <list-item>
              <p>Depending on the nature and significance of a known cardiac malformation, echocardiogram surveillance may be requested every one to five years by the managing cardiologist.</p>
            </list-item>
          </list>
          <p>In those with renal anomalies:</p>
          <list list-type="bullet">
            <list-item>
              <p>Renal function should be monitored by routine laboratory parameters for renal function (ie, serum creatinine), even if no impairment of renal function is detected on initial examination. In the first years of life, renal function should be performed every six months or once per year. If renal function remains normal, the screening intervals may be extended.</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound should be repeated if renal position anomalies could cause obstruction. The frequency depends on the clinical situation.</p>
            </list-item>
            <list-item>
              <p>In those affected individuals with thrombocytopenia and leukocytosis, blood counts should be monitored at least yearly. However, data are sparse on the natural history of thrombocytopenia in individuals with <italic toggle="yes">SALL4</italic> pathogenic variants and so it is unknown at present if more severe complications may occur.</p>
            </list-item>
          </list>
        </sec>
        <sec id="drrs.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Drugs affecting renal clearance or the inner ear should be avoided in individuals with impaired renal function and/or hearing impairment.</p>
          <p>Certain medications may be contraindicated in individuals with arrhythmias.</p>
        </sec>
        <sec id="drrs.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Although reduced penetrance does not appear to be associated with most <italic toggle="yes">SALL4</italic> pathogenic variants, unaffected persons may consider molecular genetic testing prior to family planning. Children of affected persons who are themselves not obviously affected may be tested for the pathogenic variant present in the family because individuals with the pathogenic variant should undergo clinical evaluation for hearing problems, renal disease, eye disease, and heart defects.</p>
          <p>See <xref ref-type="sec" rid="drrs.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="drrs.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="drrs.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="drrs.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">SALL4</italic>-related disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="drrs.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with a <italic toggle="yes">SALL4</italic>-related disorder have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with a <italic toggle="yes">SALL4</italic>-related disorder may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is approximately 40%-50% [J Kohlhase, unpublished observation].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with anapparent <italic toggle="yes">de novo</italic>
<italic toggle="yes">SALL4</italic> pathogenic variant include physical examination, ophthalmologic examination for structural malformations of the eyes as well as eye movement disorders, examination of the limbs (x-rays of the forearms), examination of the heart, ultrasound examination of the kidneys, and molecular genetic testing if the <italic toggle="yes">SALL4</italic> pathogenic variant has been identified in the proband.</p>
            </list-item>
          </list>
          <p>Note: Although most individuals diagnosed with a <italic toggle="yes">SALL4</italic>-related disorder have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has a <italic toggle="yes">SALL4</italic> pathogenic variant, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be about 1%-5% because of the possibility of germline mosaicism [J Kohlhase, unpublished observation].</p>
            </list-item>
            <list-item>
              <p>If a <italic toggle="yes">SALL4</italic> pathogenic variant cannot be detected in DNA extracted from the leukocytes of either parent, the two possible explanations are germline mosaicism in a parent or <italic toggle="yes">de novo</italic> mutation in the proband. Although no instances of germline mosaicism have been reported to date, it remains a possibility.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">SALL4</italic>-related disorder has a 50% chance of inheriting the pathogenic variant.</p>
          <p>
            <bold>Other family members of a proband.</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has a <italic toggle="yes">SALL4</italic> pathogenic variant, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="drrs.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="drrs.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, the pathogenic variant likely occurred <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity/maternity (in case of assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="drrs.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing. Although such testing can determine whether or not the fetus has inherited the <italic toggle="yes">SALL4</italic> pathogenic variant, it cannot predict which manifestations will be present or the severity of the manifestations. High-resolution ultrasound examination is therefore recommended to evaluate the fetus for phenotypic manifestations.</p>
          <p>A <italic toggle="yes">SALL4</italic> pathogenic variant may be detected for the first time in a family if radial malformations are detected on ultrasound examination as an incidental prenatal finding and prenatal genetic analysis reveals a <italic toggle="yes">SALL4</italic> pathogenic variant. If a larger deletion is found, chromosomal microarray analysis may be used to determine if neighboring genes, in additional to <italic toggle="yes">SALL4</italic>, are included in the deletion (see <xref ref-type="sec" rid="drrs.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
          <p>Requests for prenatal testing for conditions which (like <italic toggle="yes">SALL4</italic>-related disorders) usually do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="drrs.Resources">
        <title>Resources</title>
      </sec>
      <sec id="drrs.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">SALL4</italic> occupies about 18 kb in the genome (start codon to stop codon). It contains four coding exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020436.3">NM_020436.3</ext-link>). Two additional non-coding exons have been described, possibly resulting in alternative transcripts For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="drrs" object-id="drrs.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> At least 29 different benign variants are currently known (see <related-object source-id="gene" document-id="drrs" object-id="drrs.molgen.TA">Table A</related-object>, HGMD) [<xref ref-type="bibr" rid="drrs.REF.kohlhase.2005.176">Kohlhase et al 2005</xref>; J Kohlhase, unpublished results].</p>
        <p><bold>Pathogenic allelic variants.</bold> Excluding deletions and duplications affecting one or more exons<bold>,</bold> 29 of 31 reported and confirmed pathogenic variants predict premature protein truncation and are distributed over exons 2 and 3 of the gene [<xref ref-type="bibr" rid="drrs.REF.albaradie.2002.1195">Al-Baradie et al 2002</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2002.2979">Kohlhase et al 2002</xref>, <xref ref-type="bibr" rid="drrs.REF.brassington.2003.74">Brassington et al 2003</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2003.473">Kohlhase et al 2003</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2005.176">Kohlhase et al 2005</xref>, <xref ref-type="bibr" rid="drrs.REF.terhal.2006.222">Terhal et al 2006</xref>, <xref ref-type="bibr" rid="drrs.REF.paradisi.2007.326">Paradisi &#x00026; Arias 2007</xref>]. One insertion/deletion was found in intron 3/exon 4 [J Kohlhase, unpublished results]. It is likely that all of those pathogenic variants result in nonsense-mediated decay of the transcript and therefore haploinsufficiency of SALL4 protein. Only one missense variant has been shown so far to be clearly pathogenic and to affect the DNA binding capacity of a zinc finger domain [<xref ref-type="bibr" rid="drrs.REF.miertus.2006.154">Miertus et al 2006</xref>].</p>
        <p>All known pathogenic variants are unique to a single family with two exceptions: c.2593C&#x0003e;T and c.496dupC [<xref ref-type="bibr" rid="drrs.REF.albaradie.2002.1195">Al-Baradie et al 2002</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2003.473">Kohlhase et al 2003</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2005.176">Kohlhase et al 2005</xref>]. The pathogenic variant c.2593C&#x0003e;T caused a mild phenotype in one family and a severe phenotype in another family.</p>
        <p>Eleven deletions including one or more exons were found in families with DRRS/Okihiro syndrome or acro-renal-ocular syndrome. Seven families had heterozygous deletions of all four exons: two with deletions of exons 1-3, one with deletion of exon 1, and one with deletion of exon 4 [<xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2007.830">Borozdin et al 2007</xref>, <xref ref-type="bibr" rid="drrs.REF.aradhya.2012.594">Aradhya et al 2012</xref>, <xref ref-type="bibr" rid="drrs.REF.tomitamitchell.2012.518">Tomita-Mitchell et al 2012</xref>].</p>
        <table-wrap id="drrs.T.sall4_pathogenic_allelic_variants" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">SALL4</italic> Pathogenic Allelic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.496dupC</td>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln166ProfsTer15</td>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020436.3">NM_020436.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_065169.1">NP_065169.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2593C&#x0003e;T</td>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg865Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2663A&#x0003e;G</td>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His888Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2713C&#x0003e;T</td>
                <td headers="hd_h_drrs.T.sall4_pathogenic_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg905Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="drrs.TF.2.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">SALL4</italic> encodes sal-like protein 4 (SALL4), a C2H2 (Kr&#x000fc;ppel-like) zinc finger transcription factor of the SAL type [<xref ref-type="bibr" rid="drrs.REF.kohlhase.2002.2979">Kohlhase et al 2002</xref>]. SALL4 appears to be an essential developmental regulator. The murine homolog is essential for the development of the epiblast and primitive endoderm from the inner embryonic cell mass [<xref ref-type="bibr" rid="drrs.REF.elling.2006.16319">Elling et al 2006</xref>]. No embryonic or extra-embryonic endoderm stem cell lines can be established if Sall4 is missing. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells [<xref ref-type="bibr" rid="drrs.REF.wu.2006.24090">Wu et al 2006</xref>].</p>
        <p>Murine Sall4 cooperates with Sall1 in anorectal, heart, brain, and kidney development [<xref ref-type="bibr" rid="drrs.REF.sakakiyumoto.2006.3005">Sakaki-Yumoto et al 2006</xref>]. Together with Tbx5, Sall4 is required for patterning and morphogenesis of the first digit of the upper limbs, with the gene <italic toggle="yes">Sall4</italic> being regulated by Tbx5 in mouse [<xref ref-type="bibr" rid="drrs.REF.koshibatakeuchi.2006.175">Koshiba-Takeuchi et al 2006</xref>] and zebrafish models [<xref ref-type="bibr" rid="drrs.REF.harvey.2006.1165">Harvey &#x00026; Logan 2006</xref>], and acting together with Tbx5 on Fgf signaling, shown only in the mouse. Murine Sall4 acts in a synergistic manner together with Tbx5 in the forelimbs or with Tbx4 in the hindlimbs via direct effects on the <italic toggle="yes">Fgf10</italic> promoter [<xref ref-type="bibr" rid="drrs.REF.koshibatakeuchi.2006.175">Koshiba-Takeuchi et al 2006</xref>]. In the heart, Sall4 and Tbx5 act synergistically on the <italic toggle="yes">Gja5</italic> promotor, but antagonistically on the gene <italic toggle="yes">Nppa</italic> [<xref ref-type="bibr" rid="drrs.REF.koshibatakeuchi.2006.175">Koshiba-Takeuchi et al 2006</xref>]. Nothing is yet known about the function of Sall4 in brain, especially brain stem development.</p>
        <p>In the case of Wnt, Sall4 can be activated by Tcf4/Lef1 transcription factors [<xref ref-type="bibr" rid="drrs.REF.b_hm.2006.898">B&#x000f6;hm et al 2006</xref>] and <italic toggle="yes">Sall4</italic> variants in mice exhibit genetic interactions with beta-catenin, a key Wnt mediator [<xref ref-type="bibr" rid="drrs.REF.uez.2008.463">Uez et al 2008</xref>].</p>
        <p>Apart from its role in embryonic and stem cell development, Sall4 is involved in malignant transformation. In mouse, Sall4-mediated repression of <italic toggle="yes">Pten</italic> and activation of <italic toggle="yes">Bmi1</italic> are linked to leukemic transformation [<xref ref-type="bibr" rid="drrs.REF.yang.2007.10494">Yang et al 2007</xref>, <xref ref-type="bibr" rid="drrs.REF.yang.2008.805">Yang et al 2008</xref>, <xref ref-type="bibr" rid="drrs.REF.lu.2009.e5577">Lu et al 2009</xref>]. More than 1000 putative Sall4 target genes were identified, including many known to have roles in stem cell self-renewal and blood differentation [<xref ref-type="bibr" rid="drrs.REF.yang.2008.805">Yang et al 2008</xref>, <xref ref-type="bibr" rid="drrs.REF.gao.2013.1413">Gao et al 2013</xref>]. Since human <italic toggle="yes">SALL4</italic> is upregulated in some tumor types, especially hepatocellular carcinoma [<xref ref-type="bibr" rid="drrs.REF.yong.2013.2266">Yong et al 2013</xref>], cancer-related targets are being sought. One direct target is <italic toggle="yes">ABCA3</italic>, encoding a ATP-binding cassette (ABC) drug transport protein, which contributes to chemotherapeutic drug resistance [<xref ref-type="bibr" rid="drrs.REF.jeong.2011.e18372">Jeong et al 2011</xref>].</p>
        <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">SALL4</italic> pathogenic variants likely lead to haploinsufficiency of SALL4, since all but two pathogenic variants are expected to undergo nonsense-mediated decay, and deletions of the whole gene appear to result in the same phenotype [<xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>, <xref ref-type="bibr" rid="drrs.REF.kohlhase.2005.176">Kohlhase et al 2005</xref>].</p>
        <p>One pathogenic variant, p.Arg905Ter [<xref ref-type="bibr" rid="drrs.REF.terhal.2006.222">Terhal et al 2006</xref>], is expected to escape nonsense-mediated mRNA decay and to result in a truncated protein with one nonfunctional zinc finger domain.</p>
        <p>Another pathogenic variant, p.His888Arg, exchanges one of the essential amino acids for zinc coordination in a zinc finger and is predicted to result in increased DNA binding of the respective zinc finger.</p>
        <p>Eleven deletions that include one or more exons were found in families with DRRS/Okihiro syndrome or acro-renal-ocular syndrome. Seven families had heterozygous deletions : two with deletions of exons 1-3, one with deletion of exon 1, and one with deletion of exon 4 [<xref ref-type="bibr" rid="drrs.REF.borozdin.2004a.e113">Borozdin et al 2004a</xref>, <xref ref-type="bibr" rid="drrs.REF.borozdin.2007.830">Borozdin et al 2007</xref>, <xref ref-type="bibr" rid="drrs.REF.aradhya.2012.594">Aradhya et al 2012</xref>, <xref ref-type="bibr" rid="drrs.REF.tomitamitchell.2012.518">Tomita-Mitchell et al 2012</xref>]. The detection of deletions including the complete coding regions in patients with a clear DRRS phenotype confirmed that haploinsufficiency for SALL4 is the pathogenic mechanism leading to the phenotype [<xref ref-type="bibr" rid="drrs.REF.borozdin.2007.830">Borozdin et al 2007</xref>], and the detection of deletions including neighboring genes in patients with intellectual disability/developmental delay and DRRS showed that these features are not part of the phenotypic spectrum of <italic toggle="yes">SALL4</italic> pathogenic variants but are caused by the deletion of neighboring genes.</p>
      </sec>
      <sec id="drrs.References">
        <title>References</title>
        <sec id="drrs.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="drrs.Literature_Cited.reflist0">
            <ref id="drrs.REF.albaradie.2002.1195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Baradie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St Hilaire</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martonyi</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okihiro</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engle</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>1195</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12395297</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.albers.2012">
              <mixed-citation publication-type="other">Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley JD, Cvejic A, Kostadima M, Bertone P, Breuning MH, Debili N, Deloukas P, Favier R, Fiedler J, Hobbs CM, Huang N, Hurles ME, Kiddle G, Krapels I, Nurden P, Ruivenkamp CA, Sambrook JG, Smith K, Stemple DL, Strauss G, Thys C, van Geet C, Newbury-Ecob R, Ouwehand WH, Ghevaert C. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet. 2012;44:435-9, S1-2.</mixed-citation>
            </ref>
            <ref id="drrs.REF.aradhya.2012.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aradhya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nwokekeh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stafford</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compton</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchy</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders.</article-title>
                <source>Genet Med.</source>
                <year>2012</year>
                <volume>14</volume>
                <fpage>594</fpage>
                <lpage>603</lpage>
                <pub-id pub-id-type="pmid">22382802</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.arias.1980.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penchaszadeh</surname>
                    <given-names>VB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto-Cisternas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larrauri</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The IVIC syndrome: a new autosomal dominant complex pleiotropic syndrome with radial ray hypoplasia, hearing impairment, external ophthalmoplegia, and thrombocytopenia.</article-title>
                <source>Am J Med Genet.</source>
                <year>1980</year>
                <volume>6</volume>
                <fpage>25</fpage>
                <lpage>59</lpage>
                <pub-id pub-id-type="pmid">7395922</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.b_hm.2006.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000f6;hm</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sustmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhelm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway.</article-title>
                <source>Biochem Biophys Res Commun.</source>
                <year>2006</year>
                <volume>348</volume>
                <fpage>898</fpage>
                <lpage>907</lpage>
                <pub-id pub-id-type="pmid">16899215</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.borozdin.2004a.e113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borozdin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boehm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leipoldt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilhem</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muhlendyck</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giray</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>SALL4 deletions are a common cause of Okihiro and acro-renal-ocular syndromes and confirm haploinsufficiency as the pathogenetic mechanism.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e113</fpage>
                <pub-id pub-id-type="pmid">15342710</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.borozdin.2007.830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borozdin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Boehm</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leipoldt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Multigene deletions on chromosome 20q13.13-q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay.</article-title>
                <source>Hum Mutat</source>
                <volume>28</volume>
                <fpage>830</fpage>
                <pub-id pub-id-type="pmid">17623483</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.borozdin.2004b.e102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borozdin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannibal</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e102</fpage>
                <pub-id pub-id-type="pmid">15286162</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.brassington.2003.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brassington</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toydemir</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roeder</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutherford</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitby</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorde</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>74</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">12789647</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.elling.2006.16319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elling</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klasen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anlag</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treier</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Murine inner cell mass-derived lineages depend on Sall4 function.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>103</volume>
                <fpage>16319</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">17060609</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.ferrell.1966.630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferrell</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>RV</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1966</year>
                <article-title>Simultaneous occurrence of the Holt-Oram and the Duane syndromes.</article-title>
                <source>J Pediatr</source>
                <volume>69</volume>
                <fpage>630</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">5921340</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.gao.2013.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimitrov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tatetsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenen</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.</article-title>
                <source>Blood.</source>
                <year>2013</year>
                <volume>121</volume>
                <fpage>1413</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">23287862</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.greenhalgh.2002.876">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Greenhalgh</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ancliff</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschuuren-Bemelmans</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Thrombocytopenia-absent radius syndrome: a clinical genetic study.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>876</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12471199</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.halal.1984.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homsy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perreault</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Acro-renal-ocular syndrome: autosomal dominant thumb hypoplasia, renal ectopia, and eye defect.</article-title>
                <source>Am J Med Genet</source>
                <volume>17</volume>
                <fpage>753</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">6426304</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.harvey.2006.1165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Logan</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>sall4 acts downstream of tbx5 and is required for pectoral fin outgrowth.</article-title>
                <source>Development</source>
                <volume>133</volume>
                <fpage>1165</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">16501170</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.hayes.1985.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hayes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polomeno</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>The Okihiro syndrome of Duane anomaly, radial ray abnormalities, and deafness.</article-title>
                <source>Am J Med Genet</source>
                <volume>22</volume>
                <fpage>273</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">4050857</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.jeong.2011.e18372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cui</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.</article-title>
                <source>PLoS One.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>e18372</fpage>
                <pub-id pub-id-type="pmid">21526180</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.klopocki.2007.232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klopocki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trotier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleischhauer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenhalgh</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habenicht</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konig</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ullmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>80</volume>
                <fpage>232</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">17236129</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.kohlhase.2005.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotzot</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceylaner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froster</surname>
                    <given-names>UG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montgomery</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro-renal-ocular syndrome, and related disorders.</article-title>
                <source>Hum Mutat</source>
                <volume>26</volume>
                <fpage>176</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16086360</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.kohlhase.2002.2979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kispert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Okihiro syndrome is caused by SALL4 mutations.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2979</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">12393809</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.kohlhase.2003.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammed</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>473</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12843316</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.koshibatakeuchi.2006.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koshiba-Takeuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeuchi</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arruda</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kathiriya</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruneau</surname>
                    <given-names>BG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>175</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16380715</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.lu.2009.e5577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silberstein</surname>
                    <given-names>LE</given-names>
                  </name>
                </person-group>
                <article-title>Yupoma, Chai L. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex.</article-title>
                <source>PLoS One.</source>
                <year>2009</year>
                <volume>4</volume>
                <fpage>e5577</fpage>
                <pub-id pub-id-type="pmid">19440552</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.mccann.2005.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A family with Duane anomaly and distal limb abnormalities: a further family with the arthrogryposis-ophthalmoplegia syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>139A</volume>
                <fpage>123</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16278891</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.mefford.2008.1685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mefford</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharp</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itsara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buysse</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maloney</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crolla</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baralle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Ravel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bongers</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bena</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Male</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaunt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonic</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nik-Zainal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firth</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parkin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fichera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reitano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo Giudice</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casuga</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broomer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conrad</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwerzmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000e4;ber</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tobias</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lilley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armengol</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spysschaert</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Coene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speleman</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Binsbergen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelen</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochstenbach</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poot</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallagher</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gill</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McClellan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Regan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonarakis</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estivill</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menten</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutcliffe</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veltman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willatt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassabehji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>EE</given-names>
                  </name>
                </person-group>
                <article-title>Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes.</article-title>
                <source>N Engl J Med.</source>
                <year>2008</year>
                <volume>359</volume>
                <fpage>1685</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">18784092</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.miertus.2006.154">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miertus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borozdin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frecer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertok</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amoroso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miertus</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A SALL4 zinc finger missense mutation predicted to result in increased DNA binding affinity is associated with cranial midline defects and mild features of Okihiro syndrome.</article-title>
                <source>Hum Genet</source>
                <volume>119</volume>
                <fpage>154</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">16402211</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.miller.1999.306">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000f6;mland</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.</article-title>
                <source>Teratology.</source>
                <year>1999</year>
                <volume>60</volume>
                <fpage>306</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10525208</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.okihiro.1977.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Okihiro</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>BK</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Duane syndrome and congenital upper-limb anomalies. A familial occurrence.</article-title>
                <source>Arch Neurol</source>
                <volume>34</volume>
                <fpage>174</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">843249</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.paradisi.2007.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paradisi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arias</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>IVIC syndrome is caused by a c.2607delA mutation in the SALL4 locus.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143</volume>
                <fpage>326</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">17256792</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.powell.1999.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaelis</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Townes-Brocks syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>36</volume>
                <fpage>89</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10051003</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.sakakiyumoto.2006.3005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sakaki-Yumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takasato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kodama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aburatani</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishinakamura</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development.</article-title>
                <source>Development</source>
                <volume>133</volume>
                <fpage>3005</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">16790473</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.temtamy.1978">
              <mixed-citation publication-type="book">Temtamy SA, McKusick VA. <italic toggle="yes">The Genetics of Hand Malformations</italic>. New York, NY: Alan R Liss; 1978:133-5</mixed-citation>
            </ref>
            <ref id="drrs.REF.temtamy.1975.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Temtamy</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoukry</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghaly</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Meligy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulos</surname>
                    <given-names>SY</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>The Duane radial dysplasia syndrome: an autosomal dominant disorder.</article-title>
                <source>Birth Defects Orig Art Ser</source>
                <volume>XI</volume>
                <fpage>344</fpage>
                <lpage>5</lpage>
              </element-citation>
            </ref>
            <ref id="drrs.REF.terhal.2006.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terhal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A family with features overlapping Okihiro syndrome, hemifacial microsomia and isolated Duane anomaly caused by a novel SALL4 mutation.</article-title>
                <source>Am J Med Genet A</source>
                <volume>140</volume>
                <fpage>222</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16411190</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.tomitamitchell.2012.518">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomita-Mitchell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahnke</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Struble</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuffnell</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamm</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hidestrand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goetsch</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bick</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broeckel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelech</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tweddell</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Human gene copy number spectra analysis in congenital heart malformations.</article-title>
                <source>Physiol Genomics.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>518</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">22318994</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.uez.2008.463">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lickert</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlhase</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Angelis</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hn</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wurst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Floss</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo.</article-title>
                <source>Genesis.</source>
                <year>2008</year>
                <volume>46</volume>
                <fpage>463</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">18781635</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.wu.2006.24090">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loh</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sze</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells.</article-title>
                <source>J Biol Chem</source>
                <volume>281</volume>
                <fpage>24090</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16840789</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.yang.2008.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowles</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alipio</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>SALL4 is a key regulator of survival and apoptosis in human leukemic cells.</article-title>
                <source>Blood.</source>
                <year>2008</year>
                <volume>112</volume>
                <fpage>805</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">18487508</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.yang.2007.10494">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fink</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silberstein</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amin</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2007</year>
                <volume>104</volume>
                <fpage>10494</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17557835</pub-id>
              </element-citation>
            </ref>
            <ref id="drrs.REF.yong.2013.2266">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimitrov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawasaki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravikumar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tian</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poon</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luk</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dan</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salto-Tellez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chai</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenen</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <article-title>Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.</article-title>
                <source>N Engl J Med.</source>
                <year>2013</year>
                <volume>368</volume>
                <fpage>2266</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">23758232</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="drrs.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="drrs.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The author's research has received funding from the Wilhelm-Sander-Stiftung of Germany, a non-profit organization funding medical research, and from the Deutsche Forschungsgemeinschaft.</p>
        </sec>
        <sec id="drrs.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.humangenetik-freiburg.de/?lang=en">Human Genetics Freiburg</ext-link>
          </p>
        </sec>
        <sec id="drrs.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 March 2008 (cd) Revision: FISH analysis available on a clinical basis</p>
            </list-item>
            <list-item>
              <p>19 January 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 August 2004 (ca) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1 March 2004 (jk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
